These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11589253

  • 1. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
    Crim C, Pierre LN, Daley-Yates PT.
    Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
    [Abstract] [Full Text] [Related]

  • 2. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT, Deans A, Mehta R, Sousa AR.
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [Abstract] [Full Text] [Related]

  • 3. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [Abstract] [Full Text] [Related]

  • 4. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
    Lumry WR.
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
    [Abstract] [Full Text] [Related]

  • 5. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 7. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M, Jarvis B.
    Drugs; 2001 Jul; 61(9):1325-50. PubMed ID: 11511026
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C.
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [Abstract] [Full Text] [Related]

  • 10. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H, Meltzer EO.
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [Abstract] [Full Text] [Related]

  • 11. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
    Mak KK, Ku MS, Lu KH, Sun HL, Lue KH.
    Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
    [Abstract] [Full Text] [Related]

  • 12. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
    Onrust SV, Lamb HM.
    Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
    [Abstract] [Full Text] [Related]

  • 13. Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.
    Cowie RL, Giembycz MA, Leigh R.
    Expert Opin Pharmacother; 2009 Aug; 10(12):2009-14. PubMed ID: 19618993
    [Abstract] [Full Text] [Related]

  • 14. Mometasone furoate is a less specific glucocorticoid than fluticasone propionate.
    Austin RJ, Maschera B, Walker A, Fairbairn L, Meldrum E, Farrow SN, Uings IJ.
    Eur Respir J; 2002 Dec; 20(6):1386-92. PubMed ID: 12503693
    [Abstract] [Full Text] [Related]

  • 15. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
    Meltzer EO, Bardelas J, Goldsobel A, Kaiser H.
    Treat Respir Med; 2005 Dec; 4(4):289-96. PubMed ID: 16086602
    [Abstract] [Full Text] [Related]

  • 16. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD.
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
    [Abstract] [Full Text] [Related]

  • 17. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT, Richards DH.
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [Abstract] [Full Text] [Related]

  • 18. Effect of mometasone furoate by topical application on allergic rhinitis model in rats.
    Sugimoto Y, Ishizawa K, Saitou K, Suzuki G, Tarumi T, Nakahara H, Kirino Y, Kamei C.
    Pharmacology; 2000 Aug; 61(2):91-5. PubMed ID: 10940782
    [Abstract] [Full Text] [Related]

  • 19. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS.
    Allergy Asthma Proc; 2011 Aug; 32(6):413-8. PubMed ID: 22221434
    [Abstract] [Full Text] [Related]

  • 20. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM.
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.